Top Markets
Coin of the day
Oruka Therapeutics, Inc. Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc.

ORKA
Kedudukan dalam Saham #3144
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
Harga Saham
$100.91
Disegerakkan terakhir: 2026-08-25
Modal Pasaran
$6.09B
Perubahan (1 hari)
-1.47%
Perubahan (1 tahun)
581.36%
Negara
US
Perdagangan Oruka Therapeutics, Inc. (ORKA)

Kategori

Sejarah pecahan saham untuk Oruka Therapeutics, Inc. (ORKA)
Saham Oruka Therapeutics, Inc. (simbol: ORKA) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 26, 2026.
Satu saham ORKA yang dibeli sebelum Aug 26, 2026 kini bersamaan dengan 0 saham ORKA.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH